Free Newsletter
Appeals swamp NIH’s Undiagnosed Diseases project
The newly unveiled Undiagnosed Diseases Program at the NIH is billed as a new research program that will advance genetics work as it helps provide help to people with mystery ailments--and it's already been overwhelmed by the response. In a feature in Newsweek, the project leader notes that the program--a multidisciplinary approach to solving complex medical riddles--has only three full-time workers and has already received more than 200 urgent appeals for help.
"This is a research program," said Dr. William Gahl, the clinical director of the National Human Genome Research Institute. "We won't be able to help everyone who seeks our care."
Gahl suggested that the NIH may want to commit more money to the program, but with funding capped for years, no one expects a big budget increase anytime soon.
- read the article from Newsweek
Related Articles:
New U.S. research program to target mystery diseases
NIH expert sees new drive against rare disease
NIH budgets $71M to study rare diseases
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: